Community Fundraising August Wrap-Up

Community Fundraising August Wrap-Up

4 September 2019

It’s been a month since we highlighted some of our incredibly generous community fundraisers. We thought we’d have a look back at August and put the spotlight on more of the wonderful people who give up their time to fundraise for MIA so we can continue to edge closer to our goal of zero deaths from melanoma.

Along with the City2Surf, a number of other running events in August had our community fundraisers moving for melanoma while they raised much-needed funds for MIA. The Sunshine Coast Marathon on August 4 saw Angela Plumb and her three friends raise over $3000 in memory of Angela’s best friend Nicole who sadly passed away recently. In the Chevron City to Surf for Activ in Perth on August 25, teams Kate’s Mates and the Mel A No More’s, and runners Brad Maff, Siobhan Lloyd and Jared Williamson, collectively raised almost $6000 for Melanoma Institute Australia. Thank you to all who participated in these events!

On August 19, the ladies of Randwick Golf Club held their Annual Charity Golf Day and nominated MIA as the beneficiary for 2019. Specifically, the $14,500 raised on the day will contribute to a Phase I Clinical Trial emergency trolley and associated training. The day was a fantastic success, with golf in the morning, then lunch, a raffle, a silent auction and a presentation from MIA Speakers Hub speaker, Julie Randall. Our thanks go out to the ladies of Randwick Golf Club.

Krista Cherry’s mother-in-law, Alison, passed away before she had the chance to meet her grandson. In a beautiful gesture in lieu of gifts, Oliver chooses to raise awareness of melanoma and collect donations in memory of his grandmother. In four years of fundraising, Krista and Oliver have raised almost $6000. Thank you for your generosity!

Peta Willard was a 36-year-old mother of two young boys, a wife, daughter, granddaughter, and teacher who passed away from melanoma earlier in the year. Her touch football team, with the support of the Manly Warringah Touch Association, is rebranding as Willard’s Wombats to compete in the Senior State Cup in December. Their training, however, started with the Pub2Pub Run on August 25, where they raised over $2000 for MIA in honour of Peta and her legacy. Thank you to Willard’s Wombats, and good luck!

Peter and Julie Mansell lost their 25-year-old daughter Morgan to melanoma late last year. As Morgan also had multiple sclerosis and a rare immune deficiency, the Morgan Mansell Fund was created by Peter and Julie to honour their daughter and raise money for the causes close to her heart. With an afternoon of trivia, something Morgan loved to do, a raffle and talks on both Morgan and the Fund held on August 25, the inaugural fundraising event for the Morgan Mansell Fund was a great success.

On August 30, the annual North Queensland Air Conditioning and Refrigeration Golf Day was held at Rowes Bay Golf Club, this year raising funds for MIA in support of their industry colleague and MIA patient, Scott Buckley. A day of golf, lunch and raffles with amazing prizes donated by the community, the day was topped off with speeches from Scott and Melanoma March Townsville Committee Chair Kayla Smith.

What causes melanoma in 90% of young Australians?
19 Oct 2017

What causes melanoma in 90% of young Australians?

New research shows potentially deadly UV damage can appear decades earlier than you think.

Early lymph node check is saving lives in melanoma patients
19 Oct 2017

Early lymph node check is saving lives in melanoma patients

Early lymph node check is saving lives in melanoma patients

Congratulations to Associate Professor Anne Cust
13 Oct 2017

Congratulations to Associate Professor Anne Cust

We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.

Smoking linked to increased risk of melanoma spreading
12 Oct 2017

Smoking linked to increased risk of melanoma spreading

New research has shown that melanoma patients who smoke have an increased risk of their disease progressing compared to patients who do not smoke.

Research boost to improve outcomes for melanoma patients
11 Oct 2017

Research boost to improve outcomes for melanoma patients

More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.

Highlights in melanoma research from ESMO
21 Sep 2017

Highlights in melanoma research from ESMO

The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.

Australian researchers stopping melanoma in its tracks
11 Sep 2017

Australian researchers stopping melanoma in its tracks

Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.

Virus-antibody combo shows promise for treating advanced melanoma
08 Sep 2017

Virus-antibody combo shows promise for treating advanced melanoma

A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.

It's time to outlaw sunburn on reality TV shows - enough is enough
31 Jul 2017

It's time to outlaw sunburn on reality TV shows - enough is enough

It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.

Identifying markers for optimal response
28 Jul 2017

Identifying markers for optimal response

Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?

Global Melanoma Research Report - July
20 Jul 2017

Global Melanoma Research Report - July

In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.

A day in the life of... Sarah Lane
14 Jul 2017

A day in the life of... Sarah Lane

Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process. 

Differentiating moles from melanoma
14 Jul 2017

Differentiating moles from melanoma

Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.

Introducing SunSense Sunscreen
11 Jul 2017

Introducing SunSense Sunscreen

We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business. 

Identifying hidden melanoma
07 Jul 2017

Identifying hidden melanoma

New MIA research revealed dermoscopy features that can help detect desmoplastic melanoma.

60 Minutes' MIA Patient Feature Program
04 Jul 2017

60 Minutes' MIA Patient Feature Program

Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here

Training our future melanoma experts
22 Jun 2017

Training our future melanoma experts

Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.

Update from ASCO 2017
17 Jun 2017

Update from ASCO 2017

Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.

Diagnosing melanoma of the mouth
16 Jun 2017

Diagnosing melanoma of the mouth

MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.

New practice-changing research will reduce the need for major surgery in many melanoma patients
09 Jun 2017

New practice-changing research will reduce the need for major surgery in many melanoma patients

New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.